D. Boral Capital Acted as Sole Bookrunner to Globa Terra Acquisition Corporation (Nasdaq: GTERU) in Connection with its $175,000,000 Initial Public Offering
D. Boral Capital acted as Sole Bookrunner to Vendome Acquisition Corporation I (Nasdaq: VNMEU) in connection with its $200 Million Initial Public Offering
D. Boral Capital acted as Exclusive Placement Agent to Luminar Technologies (NASDAQ: LAZR) in connection with its up to $200.0 Million Equity Linked Securities Offering
D. Boral Capital Acted as Capital Markets Advisor to Global Star Acquisition Inc. (NYSE: GLST) in connection with its Completed Business Combination with K Enter Holdings Inc.
D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) in connection with its $13.5 Million Initial Public Offering
D. Boral Capital is Acting as Exclusive Placement Agent to Nature’s Miracle Holding Inc. (OTCQB: NMHI) in connection with its Private Placement for up to $20 Million
D. Boral Capital Acted as Sole Bookrunner to Globa Terra Acquisition Corporation (Nasdaq: GTERU) in Connection with its $175,000,000 Initial Public Offering
D. Boral Capital acted as Exclusive Placement Agent to Luminar Technologies (NASDAQ: LAZR) in connection with its up to $200.0 Million Equity Linked Securities Offering
D. Boral Capital Acted as Capital Markets Advisor to Global Star Acquisition Inc. (NYSE: GLST) in connection with its Completed Business Combination with K Enter Holdings Inc.
D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) in connection with its $13.5 Million Initial Public Offering
D. Boral Capital is Acting as Exclusive Placement Agent to Nature’s Miracle Holding Inc. (OTCQB: NMHI) in connection with its Private Placement for up to $20 Million